PATIENT AND PHYSICIAN SATISFACTION OF TREATMENT WITH ECULIZUMAB OR RAVULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM A REAL-WORLD DISEASE-SPECIFIC PROGRAMME

被引：0
|
作者：
Fureder, W. [1 ]
Mellor, J. [2 ]
Earl, L. [2 ]
Wang, A. [3 ]
Patel, Y. [1 ,3 ]
Myren, K. J. [1 ,3 ]
Nagalla, S. [4 ]
机构：
[1] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med I, Vienna, Austria
[2] Adelphi Real World, Bollington, England
[3] Alexion, Boston, MA USA
[4] Miami Canc Inst, Benign Hematol, Miami, FL USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR187
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [41] Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare
    Guckenberger, M.
    Ricardi, U.
    Scorsetti, M.
    Balermpas, P.
    Lievens, Y.
    Alongi, F.
    Livi, L.
    Braam, P.
    Jereczek-Fossa, B. A.
    Stellamans, K.
    Verbeke, L.
    Peulen, H.
    Khanfir, K.
    Ramella, S.
    Zilli, T.
    Geets, X.
    Hemmatazad, H.
    Ivaldi, G. B.
    Ratosa, I.
    Jeene, P.
    Fournier, B.
    Fortpied, C.
    Ost, P.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S568 - S569
  • [42] Features of Disease Severity Associated with Patient Satisfaction with Biologic Treatment: Results from the Abatacept Best Care Real-World Study
    Haraoui, Boulos
    Pope, Janet
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Maoui, Meryem
    Bessette, Louis
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 853 - 854
  • [43] Features of Disease Severity Associated with Patient Satisfaction with Biologic Treatment: Results from the Abatacept Best Care Real-World Study
    Haraoui, Boulos
    Pope, Janet E.
    Rampakakis, Emmanouil
    Vaillancourt, Julie
    Maoui, Meryem
    Bessette, Louis
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [44] Results of VOICE: a global survey of disease-specific knowledge and perspectives of real-world patients with CLL
    Tam, Constantine
    Pinilla-Ibarz, Javier
    Castillo, Carolina G.
    Fenili, Ana Cristina
    Huntley, Kathryn
    Karakus, Volkan
    Mattar, Mervat
    Miroli, Miguel A.
    Moura, Catherine
    Pavlovsky, Miguel
    Piotrowski, Fernando
    Simkovic, Martin
    Stilgenbauer, Stephan
    [J]. BLOOD ADVANCES, 2023, 7 (22) : 6819 - 6828
  • [45] Transfusion Requirements in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria with or without a History of Bone Marrow Disorder Receiving Ravulizumab and Eculizumab: Results from a Phase 3 Non-Inferiority Study Extension
    Risitano, Antonio
    Jang, Jun-Ho
    Gyeong-Won, Lee
    Wanachiwanawin, Wanchai
    Schrezenmeier, Hubert
    Yonemura, Yuji
    Munir, Talha
    Pavani, Rodrigo
    Wang, Jimmy
    Kulagin, Alexander D.
    Kulasekararaj, Austin
    De Fontbrune, Flore Sicre
    Roth, Alexander
    [J]. BLOOD, 2020, 136
  • [46] Transfusion requirements in adult patients with paroxysmal nocturnal hemoglobinuria with or without a history of bone marrow disorder receiving ravulizumab and eculizumab: results from a phase 3 non-inferiority study extension
    Risitano, A.
    Munir, T.
    Jang, J. Ho
    Lee, G-W
    Wanachiwanawin, W.
    Schrezenmeier, H.
    Yonemura, Y.
    Pavani, R.
    Wang, J.
    Kulagin, A.
    Kulasekararaj, A.
    de Fontbrune, F. Sicre
    Roeth, A.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 203 - 204
  • [47] Clinical Profile and Long-Term Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in a Real-World Setting: High Frequency of Anemia Despite Decreased Intravascular Hemolysis
    Versmold, Katharina
    Alashkar, Ferras
    Raiser, Carina
    Ofori-Asenso, Richard
    Xu, Tao
    Liu, Yutong
    Katz, Pablo
    Shang, Aijing
    Roeth, Alexander
    [J]. BLOOD, 2021, 138
  • [48] EXPLORING THE REAL WORLD SETTING OF CHRONIC KIDNEY DISEASE PATIENT AND PHYSICIAN BEHAVIORS ACROSS COUNTRIES: DISEASE-SPECIFIC PROGRAMMES
    Piercy, J.
    Ozbay, A. B.
    Taylor-Stokes, G.
    Marx, S. E.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A209 - A209
  • [49] Results from a phase 3, multicenter, noninferiority study of ravulizumab (ALXN1210) versus eculizumab (ECU) in adult patients (PTS) with paroxysmal nocturnal hemoglobinuria (PNH) naive to complement inhibitors (CI)
    Schrezenmeier, H.
    Lee, J. W.
    Rottinghaus, S. T.
    Lee, Lee L. W.
    Pessoa, V.
    Gualandro, S.
    Fuereder, W.
    Ptushkin, V.
    de Fontbrune, Sicre F.
    Volles, L.
    Shafner, L.
    Damokosh, A. I.
    Aguzzi, R.
    Pradhan, R.
    Ortiz, S.
    Hill, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 332 - +
  • [50] Real-world challenges and solutions for the selection and implementation of disease-specific PROs based on patient preferences.
    Ahmed, S.
    Visca, R.
    Gogovor, A.
    Eilayyan, O.
    [J]. QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 8 - 8
12345